4DMT Appoints Sam Moskowitz MD As Senior VP Of Lung Therapeutics
The Company’s second product candidate, 4D-710, is the first known genetic medicine to achieve successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery. 4D Molecular Therapeutics™, 4DMT™, Therapeutic Vector... 4D Molecular Therapeutics (4DMT) is a clinical-stage biotechnology company focused on developing gene therapies. They use Therapeutic Vector Evolution to create adeno-associated virus (AAV) vectors that deliver therapeutic genes to targeted cells. Experience: 4D Molecular Therapeutics · Education: Harvard Medical School · Location: Boston · 500+ connections on LinkedIn. View SamMoskowitzMD’s profile on LinkedIn, a professional community of 1 billion members. Moskowitz is a pediatric pulmonologist in Newton, Massachusetts and is affiliated with multiple hospitals in the area, including MassGeneral Hospital for Children and Massachusetts General Hospital. SamMoskowitz, MD is a gastroenterologist in Brooklyn, NY and has over 45 years of experience in the medical field. He graduated from Albert Einstein College of Medicine in 1976. Samuel M Moskowitz, MD, is a specialist in pulmonology who treats patients in Boston, MA. They accept 2 insurance plans. Pseudomonas aeruginosa has been highlighted by the recent WHO Global Priority Pathogen List due to multidrug resistance. Without new antibiotics, polymyxins remain a last-line therapeutic option for this difficult-to-treat pathogen.Jihye Park Jihye Park. InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, today announced the appointment of Amanda J. Redig, MD, PhD, as Chief Medical Officer.
Read also: Hooters Sioux Falls Sd
